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Ultraviolet (UV)-associated cancer is the most common cancer in the United States. Approximately 90% of nonmelanoma skin cancer and 65% of
melanoma are attributable to UV exposure and theoretically could be eliminated by primary prevention measures. Safe sun strategy includes use of
sunscreens, use of protective clothing, minimization of exposure from 10 A.M. to 3 P.M., and avoidance of tanning parlors. Although more definitive data
in human populations on the effectiveness of sunscreens to prevent melanoma and skin cancer are needed, sunscreens are thought to reduce risk.
Safe sun prevention must start in childhood and adolescence when people receive most of their UV exposure. Secondary prevention through pro-
fessional and public education and early detection may further reduce melanoma mortality.- Environ Health Perspect 1 03(Suppl 8):255-257 (1995)
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Introduction
Ultraviolet (UV)-associated cancer (i.e.,
skin cancer) is the most common cancer in
the United States. In theory, we should be
able to improve skin cancer control through
both primary and secondary prevention
(1). An estimated 90% of nonmelanoma
skin cancers (squamous cell carcinoma and
basal cell carcinoma) are attributable to
cumulative UV sun exposure (2). Hence,
effective primary prevention measures (safe
sun strategy) theoretically should be able to
eliminate most of these cancers. For malig-
nant melanoma, recent estimates suggest
that perhaps 65% (worldwide) are attribut-
able to UV exposure. Therefore, primary
prevention has a possible role for this
malignancy as well (3).
In addition, early, thin, stage I mela-
noma has a very high 5-year survival rate
and is mostly curable. In contrast, late-
stage metastatic melanoma generally is
incurable (1), causing 7000 deaths a year
in this country (4). Hence, secondary pre-
vention through education, early detection,
and possibly screening could complement
primary prevention to reduce melanoma
mortality (1,5,6).
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Based on current knowledge, we can
make recommendations for primary pre-
vention through a safe sun strategy. Safe
sun currendy entails at least three elements
for persons at risk: a) use of sunscreens;
b) personal behavior changes to indude use
of natural shade, protective clothing and
hats, and minimization of exposure between
10 A.M. to 3 P.M. [the peak ultraviolet B
(UVB) time]; and c) avoidance of tanning
parlors (7). In addition, environmental
strategies to preserve atmospheric ozone are
also important primary prevention mea-
sures. This presentation focuses mainly on
the first two items: use of sunscreens and
personal behavior changes.
Primary Prevention-Safe
Sun Strategy
Use of sunscreens has increased in the
United States over the past three decades.
Sunscreens are graded according to their
solar protection factor (SPF), which ranges
from 2 to 50 or more. Sunscreens protect
against UVB and, more recently, ultravio-
let A (UVA). Experts distinguish between
sunblocks (physical blockers of UV light,
such as titanium dioxide) and sunscreens
(chemical agents that absorb UV light,
such as para-aminobenzoic acid [PABA]
esters) (7). Sunscreens prevent erythema
and sunburn in animal models and in
humans (8) and prevent squamous cell car-
cinomas in animal models (9). In addition,
in a recent randomized study in humans,
sunscreens appeared to prevent actinic ker-
atoses, which are precursors to squamous
cell carcinomas (10,11).
Despite these data, many questions still
remain about proper sunscreen use within
a safe sun strategy. We encourage people
to avoid sunburns to protect against skin
cancer (and possibly, melanoma) years
later. But, if more subtle sun damage
causes substantial immune aberrations in
humans, we may require even more com-
prehensive sun protection to improve
public health.
We also need definitive data in human
populations on the ability of sunscreens
to prevent melanoma and skin cancer.
Currently, the evidence that sunscreens
prevent skin cancer is largely restricted to
squamous cell carcinoma models in animals
(9). Obtaining such human data prospec-
tively would require decades of monitoring
and follow-up, so understandably such data
are lacking. Available case-control studies
on sunscreens and melanoma generate
mixed condusions and may be complicated
by confounding (12-14).
How should we advise the public until
these answers are available? A U.S. Food
and Drug Administration monograph has
established conditions by which over-the-
counter sunscreens are recognized as safe
and effective (15). First published in the
Federal Register in 1978, these conditions
were reviewed and updated in the 1980s
and were undergoing revision again in
1994. Suggestions from scientific groups,
consumer groups, industry officials, and
concerned citizens shaped the content of
this monograph. Hence, this very public
process has attempted to fashion a consen-
sus about what sunscreens can do and the
conditions under which they can be mar-
keted as safe and effective products. For
example, the monograph offers a suggested
label for sunscreens-"Sun Alert: The sun
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causes skin damage. Regular use of sun-
screens over the years may reduce the
chance of skin damage, some types of skin
cancer, and other harmful effects due to
the sun" (15).
Comprehensive, safe sun education
must start in childhood and adolescence
when people receive most of their UV
exposure (16). This raises many public
health challenges. First, children (and
adults) may find sunscreens messy and
inconvenient, which lowers compliance.
Also, sunscreens can occasionally cause side
effects such as dermatitis and other irrita-
tive problems. We need a better under-
standing of the effects these problems have
on compliance and must consider methods
for improvement (17).
Second, although a single bottle of
sunscreen may be relatively inexpensive,
over a long, hot summer a family could
find mounting costs prohibitive. If this is a
major problem, we need to make sun-
screens more accessible to low-income
families.
Third, to promote safe sun and ulti-
mately prevent UV-associated skin cancer,
we must alter attitudes about tanning, par-
ticularly in adolescence. One U.S. survey
indicates that two-thirds of respondents
still believe that people look more healthy
with a tan-this cultural norm may have
to be changed before we can possibly
observe improved safe sun behavior
(unpublished data). Finally, we must teach
children in an understandable way. For
example, astronomer Leith Holloway has
published the so-called shadow rule in the
photobiology literature (18)-if your
shadow is shorter than you are, it is time
to seek shade and put on sunscreen. The
American Academy of Dermatology has
started to publicize this rule through pub-
lic service announcements featuring their
official spokescritter Joel Mole.
It is difficult to accurately estimate the
number of people currently using sun-
screens in the United States. A Boston
University School of Public Health
national random-digit dial survey found
that about half the respondents who had
sunbathed on the previous day also
reported using sunscreen (Koh et al.,
unpublished data). Of these, only about
one-half of users (hence, about one-quarter
overall) used SPF 15 or greater, the level
currently advocated by most policy groups.
Men and those of lower socioeconomic sta-
tus reported lower rates of sunscreen use.
Hence, gender and social class differences
need further clarification.
Secondary Prevention
Strategies
Strategies for early detection and secondary
prevention must recognize that most mela-
nomas are asymptomatic and usually do
not cause pain, itching, or other discomfort
to the patient (1,19). Hence, only recogni-
tion by visual examination will detect these
lesions early. The potential for professional
and public education (20) in melanoma is
high-the media can help improve recog-
nition of this uniquely visual and external
tumor. All primary care practitioners should
be taught how to distinguish between ordi-
nary moles (melanocytic nevi) and malig-
nant melanoma (19,21). Since 1985, we
have promulgated the ABCD rule which
states that a mole with A, asymmetry; B,
border irregularity; C, varied or intensely
black color; and D, greater than 6 mm (the
diameter of a pencil eraser) may signify
melanoma (1,19,20). Many patients now
seek medical advice for suspect moles (after
noting ABCD qualities) that indeed are
melanomas, demonstrating that patients
can be empowered to improve their own
health. Since about half of all melanoma
patients discover their own lesions, patients
have critical roles in early detection (22).
The American Academy of Dermatol-
ogy has led national educational and early
detection efforts annually every spring since
1985. The educational campaign involves
disseminating warning signs and risk factors
for skin cancers and melanoma through the
media. Articles in newspapers and maga-
zines and on radio and television penetrate
all the top 30 television markets throughout
all 50 states each year (23). To date, these
messages have been carried as free public
service announcements by the media and
incur little cost. We must evaluate such
public education to see how much these
efforts have changed skin cancer knowledge,
attitudes, and behaviors in this country.
Screening for skin cancer has attracted
interest in recent years. Screening for any
cancer is an inherently challenging area and
in the skin cancer arena, many questions
arise. There is theoretical appeal for this
approach to cancer control. Melanoma is a
rising public health problem, early detection
is associated with cure, and the screening
tool-a visual examination by a qualified
observer (1,5,6)-requires no special tech-
nology, is noninvasive, is acceptable to the
public, and takes only a few minutes.
The ideal study design for screening for
skin cancer would be a randomized trial (as
in breast cancer and some other cancers)
(5). However, because of logistical and
funding challenges and for many other rea-
sons, no randomized trial for screening for
skin cancer exists or indeed is planned any-
where in the world (5,6). Data should soon
be emerging from an ongoing case-control
study investigating whether self-screening is
associated with lower rates of lethal mela-
noma in Connecticut (24). Short of this, a
demonstration project by the American
Academy of Dermatology has been coordi-
nating free skin cancer screenings by vol-
unteer dermatologists. Each spring, the
media advertises these sessions and some
among the general public choose to attend
to have their skin checked. These sessions
have screened over 700,000 people since
1985 (23). Of the first 400 pathology-con-
firmed melanomas found through this
effort, 90% of invasive lesions have been
thin, stage I tumors usually associated with
5-year survivals of 87% or more (23).
However, this is not a randomized trial and
lacks an appropriate control group. In
addition, because of self-selection bias and
many other biases, we cannot be certain of
its impact on melanoma mortality.
In the meantime, policy groups differ
about whether skin cancer screening should
be part of general health policy. Clearly,
these recommendations will change over
time as new data come forward. The United
States Preventive Services Task Force cur-
rently recommends skin cancer screening
for high-risk persons. In that regard, inves-
tigators from the Netherlands and the
University of Pennsylvania focus screening
on families with atypical nevi or dysplastic
nevi (25,26). These efforts for screening,
surveillance, and education have found
thinner melanomas in these groups.
Another early detection strategy may be
to target those at high risk of dying from
melanoma. Melanoma mortality is higher in
men than in women, particularly men over
age 50, who currently comprise almost half
of all melanoma deaths in the United States
(27,28). It is not known if these gender dif-
ferences are due to a different biology of
melanoma in older men, different behavioral
factors, or a combination. Some hypothesize
that older men are less aware of skin lesions
and moles than other subpopulations. Until
further data are available, it may be reason-
able to focus some of our early detection and
educational efforts to men over 50 (27,29).
With more research and better evalua-
tion of primary and secondary preventive
strategies for UV-associated cancer, we
hope that ultimately these preventive
approaches will decrease melanoma and
skin cancer incidence and mortality.
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